ArticleBMJ open2024

Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.

Toon Van Genechten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.